Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
For researchers whose metabolic study programme also involves growth factor signalling alongside lipolysis research, our IGF-1 LR3 1mg research guide covers the growth factor peptide most commonly used as a mechanistic counterpart to AOD-9604, operating through the IGF-1 receptor pathway rather than the beta-3 adrenergic system, providing a complementary non-overlapping molecular probe for multi-pathway metabolic studies
Loading phase uses higher doses (2.5-5mg) 2x weekly for 4-6 weeks to rapidly saturate tissues and initiate healing
Aging follows patterns at cellular and systemic levels
NAD+ Subcutaneous Injection Dosage Chart Subcutaneous NAD+ schedules are often planned with smaller amounts and injection volumes than clinic-based IV protocols
US$ 24.03
US$ 26.32
US$ 25.40
US$ 26.16
US$ 25.74
US$ 27.66
US$ 26.51
US$ 20.63
US$ 22.08
US$ 21.59
